392 related articles for article (PubMed ID: 21709373)
1. Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias.
Davies NM; Kehoe PG; Ben-Shlomo Y; Martin RM
J Alzheimers Dis; 2011; 26(4):699-708. PubMed ID: 21709373
[TBL] [Abstract][Full Text] [Related]
2. Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis.
Imfeld P; Bodmer M; Schuerch M; Jick SS; Meier CR
Epilepsia; 2013 Apr; 54(4):700-7. PubMed ID: 23215680
[TBL] [Abstract][Full Text] [Related]
3. Risk of Osteoporotic Fractures With Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Hypertensive Community-Dwelling Elderly.
Butt DA; Mamdani M; Gomes T; Lix L; Lu H; Tu K;
J Bone Miner Res; 2014 Nov; 29(11):2483-8. PubMed ID: 24806397
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK.
Imfeld P; Brauchli Pernus YB; Jick SS; Meier CR
J Alzheimers Dis; 2013; 35(3):565-73. PubMed ID: 23455986
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users.
de Jong HJ; Vandebriel RJ; Saldi SR; van Dijk L; van Loveren H; Cohen Tervaert JW; Klungel OH
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):835-43. PubMed ID: 22674737
[TBL] [Abstract][Full Text] [Related]
6. Associations of angiotensin targeting antihypertensive drugs with mortality and hospitalization in primary care patients with dementia.
Kehoe PG; Davies NM; Martin RM; Ben-Shlomo Y
J Alzheimers Dis; 2013; 33(4):999-1008. PubMed ID: 23076074
[TBL] [Abstract][Full Text] [Related]
7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.
Imfeld P; Bodmer M; Jick SS; Meier CR
Drug Saf; 2018 Dec; 41(12):1387-1396. PubMed ID: 30146658
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis.
Mukamal KJ; Ghimire S; Pandey R; Fiarman GS; Gautam S
Ann Epidemiol; 2012 Oct; 22(10):747-50. PubMed ID: 22867943
[TBL] [Abstract][Full Text] [Related]
10. Memory is preserved in older adults taking AT1 receptor blockers.
Ho JK; Nation DA;
Alzheimers Res Ther; 2017 Apr; 9(1):33. PubMed ID: 28446207
[TBL] [Abstract][Full Text] [Related]
11. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
[TBL] [Abstract][Full Text] [Related]
12. Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.
Happich M; Kirson NY; Desai U; King S; Birnbaum HG; Reed C; Belger M; Lenox-Smith A; Price D
J Alzheimers Dis; 2016 May; 53(1):171-83. PubMed ID: 27163798
[TBL] [Abstract][Full Text] [Related]
13. Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers.
Takeuchi K; Ideishi M; Tashiro T; Morishige N; Yamada T; Saku K; Urata H
Hypertens Res; 2005 Aug; 28(8):639-44. PubMed ID: 16392767
[TBL] [Abstract][Full Text] [Related]
14. Compliance, persistence, and switching patterns for ACE inhibitors and ARBs.
Vegter S; Nguyen NH; Visser ST; de Jong-van den Berg LT; Postma MJ; Boersma C
Am J Manag Care; 2011 Sep; 17(9):609-16. PubMed ID: 21902446
[TBL] [Abstract][Full Text] [Related]
15. Does comorbidity explain trends in prescribing of newer antihypertensive agents?
Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; de Zeeuw D; Haaijer-Ruskamp FM
J Hypertens; 2004 Nov; 22(11):2209-15. PubMed ID: 15480107
[TBL] [Abstract][Full Text] [Related]
16. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status.
Ouk M; Wu CY; Rabin JS; Jackson A; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W
Alzheimers Res Ther; 2021 Feb; 13(1):43. PubMed ID: 33573702
[TBL] [Abstract][Full Text] [Related]
17. Angiotension receptor blockers reduce the risk of dementia.
Chiu WC; Ho WC; Lin MH; Lee HH; Yeh YC; Wang JD; Chen PC;
J Hypertens; 2014 Apr; 32(4):938-47. PubMed ID: 24406780
[TBL] [Abstract][Full Text] [Related]
18. Uptake of angiotensin II receptor blockers in the treatment of hypertension.
Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; de Zeeuw D; Haaijer-Ruskamp FM
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):461-6. PubMed ID: 15912393
[TBL] [Abstract][Full Text] [Related]
19. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
[TBL] [Abstract][Full Text] [Related]
20. Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies.
Hao G; Wang Z; Guo R; Chen Z; Wang X; Zhang L; Li W
BMC Cardiovasc Disord; 2014 Oct; 14():148. PubMed ID: 25344747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
